Needle Zap® Device Could Fight AIDS – As Reported in the Mansfield News Journal

Share Article

FDA Has approved a breakthrough medical device manufactured by E Med Future, Inc. a publicly traded company (EMDF). This device destroys infectious needles onsite and prevents spread of AIDS and HIV through accidental needle sticks.

E Med Future, Inc. (OTCBB:EMDF-NEWS) announced today that the company was featured in an article by the Mansfield Journal on October 24, 2004. The article, written by Russ Kent, states that NeedleZap®, which is marketed by E Med Future, Inc. in the United States and abroad, could go a long way to halting the spread of AIDS in third world countries.

NeedleZap® is a portable needle destruction device that incinerates used hypodermic needles. When a used needle is inserted into the device -- which is roughly the size of a softball and runs on two D-sized rechargeable batteries -- the needle burns up at temperatures as high as 2,200 degrees Fahrenheit. Once destroyed, the needle can not be used again.

Dane Donahue, the Vice President of E Med Future, Inc. stated, “It (NeedleZap®) was developed to reduce needle-stick injuries. There are more than a million accidental needlesticks each year." The article also stated while “the NeedleZap® is not being marketed as a way to stem the worldwide AIDS epidemic, it could have a major effect on the problem.”

Mr. Donahue further explained that “there is a misperception that most AIDS cases are spread by sexual activity. In fact, most AIDS cases in other parts of the world are spread through the use of contaminated needles. Researchers agree the use of previously-discarded needles contributes to the spread of AIDS and other blood-borne infections like hepatitis and malaria. We are trying to end needle stick injuries.”

NeedleZap® has been approved by the Food and Drug Administration as a Class 3 medical device. It has also been approved by the European Union.

For more information about E Med Future, Inc. please contact: Matt Maguire of Big Apple Consulting USA, Inc., 1-407-884-0444 or 1-866-THE-APPLE.

Safe Harbor Act Notice: This release may contain forward-looking statements that involve risks and uncertainties, including without limitation, acceptance of the company's products, increased levels of competition, product and technological changes, the company's dependence upon financing and third- party suppliers, and other risks detailed from time to time in the company's federal filings, annual report, offering memorandum, or prospectus. Specifications are subject to change without notice.

SOURCE E Med Future, Inc.


# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patrick Downs
Visit website